The Order no. 962/21.11.2016, published in the section of “Eligible number of patients” within the website of NHIH, is defining the eligibility, monitoring and result evaluation criteria to be used during negotiation of cost-volume-results contracts for direct antiviral activity medicines in Child B or C patients

" />
Hare
HomeInsights

INDUSTRY:

Pharma

TOPIC:

Regulatory & Legal, Business & People

TITLE:

Order of The President of NHIH for the approval of eligibility, monitoring and result evaluation criteria used in decompensated cirrhosis patients treated with direct antiviral activity medicines being part of negotiation of cost-volume-results contracts

BRIEF:

The Order no. 962/21.11.2016, published in the section of “Eligible number of patients” within the website of NHIH, is defining the eligibility, monitoring and result evaluation criteria to be used during negotiation of cost-volume-results contracts for direct antiviral activity medicines in Child B or C patients

LEGAL IMPLICATIONS:

BUSINESS IMPLICATIONS:

Special Report

In an unexpected move, just before the end of 2011, ...

Case Study

Improving expenditure efficiency has been, for a ver...

Your Portal Link to Mass Media Universe.

Valuable Quarterly Romanian Market Analysis.

Ask the analyst

Tailor-made advice for you

Feature Company